U.S. Healthcare Services Stock News

Solid Power has achieved key breakthroughs in its all-solid-state battery technology, including successful integration of its battery cells into BMW's i7 test vehicles and expanded partnerships with major automakers like BMW and Ford, alongside receiving up to US$50 million in funding from the U.S. Department of Energy to support production. An important insight is that the company's recent real-world testing and enhanced collaborations signal substantial progress toward commercial adoption...

Village Super Market (VLGE.A) has grown earnings by 21.3% per year over the past five years and most recently posted a net profit margin of 2.4%, up from last year’s 2.2%. Last year’s earnings growth came in at 16%, trailing the robust five-year average. Investors are watching closely, as the company’s high quality earnings, strong valuation with a Price-To-Earnings Ratio of 8.2x (well below industry averages), and a track record of profit growth all present attractive reward signals. See our...

Graham Holdings (GHC) stock has seen some interesting moves this month, gaining about 18% over the past 3 months with a steady year-to-date return near 26%. Investors watching the company’s diverse business segments may be reassessing its long-term prospects. See our latest analysis for Graham Holdings. Graham Holdings’ share price has shown momentum lately, with a strong total shareholder return of nearly 35% over the past year and more than 180% over five years. While the latest week was...

Arrowhead Pharmaceuticals (ARWR) has just filed a request to begin Phase 1/2a clinical trials for ARO-DIMER-PA, its innovative RNAi therapy targeting mixed hyperlipidemia and related cardiovascular risk. This move highlights Arrowhead’s ongoing commitment to advancing RNAi treatment options. See our latest analysis for Arrowhead Pharmaceuticals. The ARO-DIMER-PA trial application comes on the heels of an impressive run for Arrowhead’s stock, which has nearly doubled with a 95.9% share price...

If you’ve been watching Macy’s stock lately, you’re not alone. Investors of all stripes are trying to decide whether now is the moment to buy, hold, or take profits, given that the share price has recently closed at $17.72. The past year has given Macy’s holders a reason to smile, with the stock climbing 20.6% in twelve months and an eye-opening 241.8% over five years. Even recent volatility hasn’t shaken the longer-term trend. While the last week saw a dip of 1.3%, the past month erased that...

Thinking about what to do with GE HealthCare Technologies stock? You are definitely not alone. With an impressive history and a footprint spanning medical imaging, diagnostics, and digital solutions, this is a company that always gets investors talking. But with GE HealthCare’s stock closing recently at $75.13 and price performance showing a dip of -0.5% over the past week and -17.1% in the past year, there is understandably some uncertainty about what comes next. Recent shifts across the...

In its most recent financial results, Napco Security Technologies delivered the largest analyst estimates beat among its peers, outperforming expectations by 14.1% and surprising the market with its performance. This significant outperformance came despite previous concerns about softer demand trends and subscale operations, highlighting the company's ability to deliver above expectations even in a challenging environment. We'll explore how Napco’s substantial earnings beat could reshape...

StandardAero recently announced that Michael L. Kaplan will rejoin the company as Chief Legal Officer, succeeding retiring executive Steve Sinquefield and bringing over 25 years of legal and leadership experience to the Scottsdale-based firm. Alongside this leadership change, StandardAero has achieved a 37% rise in Return On Capital Employed over the past two years, reflecting substantial operational gains. We will explore how the sharp increase in operational efficiency shapes the company’s...

If you have been watching Moody's stock lately, you are probably weighing your next move after another round of market shifts. Maybe you noticed the modest 2.1% uptick this week or the slight cooling of -3.5% over the last month and wondered, what does this really mean for long-term investors? On a longer horizon, Moody's is hardly a slow mover, with a 109.9% jump over three years and a robust 76.2% gain across five. The conversation around Moody's often comes back to its role in the...

Tarsus Pharmaceuticals (TARS) shares jumped after stronger-than-expected sales growth from Xdemvy, its prescription treatment for Demodex blepharitis. The company also announced it is preparing mid-stage trials for new pipeline therapies. See our latest analysis for Tarsus Pharmaceuticals. Tarsus Pharmaceuticals has been on an impressive run, with a 22.6% share price return over the past month and more than doubling total shareholder return at 100.8% in the last year. Recent surges reflect...

Renasant (RNST) is in the spotlight as recent commentary points to its lower profitability margins and declining earnings per share, even though revenue has continued to grow. This situation has influenced investor sentiment. See our latest analysis for Renasant. Despite positive revenue trends, Renasant's share price movement has been a bit choppy lately, with a 1-month share price return of -7.07% and a year-to-date gain of 3.39%. Still, long-term investors have enjoyed an 18.64% total...

Tenaya Therapeutics (TNYA) is generating increased investor curiosity after CEO Faraz Ali took the stage at the Cell & Gene Meeting on the Mesa. The annual Phoenix gathering often highlights fresh momentum in gene therapy players such as this one. See our latest analysis for Tenaya Therapeutics. The CEO’s high-profile appearance seems to have fueled enthusiasm, with a hefty 30-day share price return of 30.7% and a remarkable 166% surge over the past quarter. This suggests momentum is rapidly...

Earlier this week, Citigroup downgraded Boston Beer Company, citing continued sales challenges and input cost pressures impacting the company's near-term outlook. Despite persistent demand headwinds, Boston Beer maintained an earnings forecast that exceeded expectations, helping to reaffirm investor confidence in its operational resilience. We'll explore how Citigroup's renewed caution on sales momentum could shape Boston Beer's investment narrative going forward. AI is about to change...

In the past week, Whirlpool shares have reacted to growing investor concerns as the U.S. government shutdown extended into its seventh day, creating economic uncertainty and affecting multiple sectors. Delays in releasing key economic data and operational challenges, such as Federal Aviation Administration staffing issues, are fueling broader market anxiety that is impacting consumer durables companies. Analysts note that in this environment, Whirlpool's risk profile is intensified by...

In early October 2025, Brink's drew increased investor and analyst optimism following a series of earnings estimate upgrades and continued expansion in its ATM Managed Services and Digital Retail Solutions businesses. The company's active share repurchase program and efforts to diversify beyond traditional cash handling are strengthening confidence in its ability to adapt despite industry changes. We'll explore how analyst optimism tied to Brink's digital and ATM services expansion could...

Thinking about what to do with your Rithm Capital shares, or eyeing an entry point? You are not alone. The stock has darted through the past year with a mix of resilience and volatility, drawing plenty of attention along the way. While the recent month saw shares slip by 12.4%, it is worth noting that over the last year, Rithm Capital has delivered a healthy 12.8% gain. If you zoom out further, the five-year climb stands at an impressive 116.3%. That kind of long-term performance suggests...

If you are sitting on the fence about CSW Industrials, you are not alone. After a phenomenal three- and five-year run, delivering 115.1% and 196.8% returns respectively, the past year has left many investors scratching their heads. CSW Industrials’ stock closed most recently at $249.49, but it is down 33.8% over the last twelve months and has tumbled 29.0% year-to-date. Just in the past week, it slipped another 1.1%, capping off a 6.4% slide for the month. While part of this volatility can be...

PC Connection (CNXN) just delivered its fifth straight quarter of year-over-year net sales growth, supported by strong customer spending on data center refreshes and upgrades related to the Windows 11 rollout. This trend is drawing attention, especially as other sector players report mixed results. See our latest analysis for PC Connection. PC Connection’s upbeat sales streak sets it apart from peers, but the market reaction has been cautious. The current share price sits at $60.71 with a...

If you have been watching Byrna Technologies and wondering whether now is the moment to get in, you are not alone. The stock has been catching flurries of attention from investors searching for overlooked growth stories with real staying power. Over the past month, Byrna’s share price climbed 12.6%, and the one-year return sits at an impressive 58.2%. If you zoom out even further, the three-year gain of 268.9% stands out, especially considering the more recent volatility and a year-to-date...

Steven Madden (SHOO) has attracted renewed attention as investor focus shifts to its vertical integration strategy and efforts to diversify its supply chain away from China. These moves are widely seen as ways to improve profit margins and earnings stability. See our latest analysis for Steven Madden. Steven Madden’s share price has rebounded sharply with a 12% gain over the last month, reflecting a swing in sentiment as investors look past earlier concerns about tariffs and slowing growth...

Frontdoor (FTDR) has returned 13% over the past three months, catching the attention of investors looking for steady growth. The company’s recent performance adds to a year-to-date gain of 20%, which signals positive momentum. See our latest analysis for Frontdoor. Frontdoor’s recent share price momentum has been impressive, particularly when considering performance beyond the past three months. The latest rally reflects growing investor optimism. The company’s 36.8% total shareholder return...

If you’re watching Recursion Pharmaceuticals after its latest run-up, you’re not alone. In just the past week, shares have shot up 19.4%, and they’re up 31.8% over the past month. But before you jump in or count your gains, it’s worth pausing to ask whether these moves hint at new growth potential or if the market is simply repricing risk. Long-term holders have had a rockier ride, with the stock down 15.5% for the year so far and nearly flat compared to a year ago. Over the past three...

As the U.S. stock market sees fluctuations with major indices like the S&P 500 and Nasdaq hitting fresh records followed by slight retreats, investors are closely monitoring economic indicators such as Treasury yields and gold prices. In this environment, identifying undervalued stocks becomes crucial for those looking to capitalize on potential value opportunities amidst these shifting market dynamics.

As major U.S. stock indices like the S&P 500 and Nasdaq recently hit fresh records, investors are keeping a close eye on companies that demonstrate strong growth potential amid fluctuating market conditions. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may offer robust revenue expansion opportunities, such as the ones experiencing up to 16% revenue growth discussed in this...